Status:
RECRUITING
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Mastectomy
Mammaplasty
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to learn whether there is a superior fat processing method in terms of graft retention in breast reconstruction after mastectomy.
Eligibility Criteria
Inclusion
- Female;
- Documented history of previous breast surgery (either complete or partial mastectomy);
- Available harvest sites for fat grafting as documented by plastic surgeon;
- BMI \> 20;
- Anticipated harvested fat volume \> 50cc;
- Competency and willingness to provide consent
Exclusion
- Suspected or known to be pregnant
Key Trial Info
Start Date :
May 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT04891510
Start Date
May 19 2021
End Date
January 1 2027
Last Update
July 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Presbyterian - Weill Cornell Medicine
New York, New York, United States, 10021